Feeding tube placement facilitates aggressive hyperfractionated chemoradiation (HXCRT) for unresectable head and neck cancer
Aaron M. Allen(Tel Aviv University), Avraham Eisbruch(University of Michigan–Ann Arbor), Carol R. Bradford(The Ohio State University), Christina Tsien(McGill University Health Centre), Norman D. Hogikyan(Michigan Medicine), Gregory T. Wolf(University of Michigan), Susan G. Urba(University of Michigan), Douglas B. Chepeha(University of Michigan), Frank Worden(University of Michigan), Ted Teknos, Laura A. Dawson(Princess Margaret Cancer Centre)
International Journal of Radiation Oncology*Biology*Physics
September 1, 2004
Cited by 1
Related Papers
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Validation of an instrument to measure voice-related quality of life (V-RQOL)
|Journal of Voice|1999|1.1k
Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma
|Journal of Clinical Oncology|2013|841
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
|Journal of the National Comprehensive Cancer Network|2018|632
Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
|Journal of Clinical Oncology|2008|597